XERS Stock Analysis: Buy, Sell, or Hold?
XERS - Xeris Biopharma Holdings, Inc. Common Stock
$7.36
0.12 (1.66%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 02, 2026
29d
Get Alerted When XERS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called XERS this week
88% bullish • 1 bearish
88% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XERS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: XERS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.54
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.40
12.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XERS is currently trading at $7.36, which is considered slightly low relative to its 30-day fair value range of $7.19 to $7.73. The stock's valuation (Forward PE: 23.0) is in line with its historical norms (22.1). At these levels, the market is pricing in 1.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, XERS is in a downtrend. Immediate support is located at $7.04, while resistance sits at $7.85.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.14 (+53.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XERS is in a downtrend. Immediate support is located at $7.04, while resistance sits at $7.85.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.14 (+53.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$7.19 -
$7.73
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.9% below Wall St target ($11.14)
- NEUTRAL: Market pricing in 1.4% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$7.19 -
$7.73
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.05
Resistance Level
$7.85
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
23.02
Wall Street Target
$11.14
(+53.9%)
Revenue Growth (YoY)
37.1%
Profit Margin
-5.9%
Valuation Premium vs History
+1.4% premium
PE vs Historical
23.0 vs 22.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.4%
(market-implied from PE analysis)
1-Year Target
$7.34
(+1%)
2-Year Target
$7.44
(+3%)
3-Year Target
$7.55
(+4%)
3-Yr Target (if PE normalizes)
(PE: 23→22)
PE COMPRESSION
$7.25
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 399.2%)
$24.44
(+238%)
Base:
(SPY PE: 22.3, Growth: 399.2%)
$23.67
(+227%)
Bear:
(PE: 19.0, Growth: 399.2%)
$20.12
(+178%)
Last updated: January 30, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XERS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Marla Persky
SELL
15500 shares
2025-09-11
Jeffrey W Sherman
SELL
42232 shares
2025-08-28
John Johnson
SELL
107500 shares
2025-08-13
Featured in Portfolios
XERS is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
Advanced XERS Option Strategies
Professional options setups generated by AI based on today's XERS price and gamma walls.